Loading...
Update on the pharmacotherapy of cerebellar and central vestibular disorders
An overview of the current pharmacotherapy of central vestibular syndromes and the most common forms of central nystagmus as well as cerebellar disorders is given. 4-aminopyridine (4-AP) is recommended for the treatment of downbeat nystagmus, a frequent form of acquired persisting fixation nystagmus...
Na minha lista:
| Udgivet i: | J Neurol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833819/ https://ncbi.nlm.nih.gov/pubmed/27083881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-015-7987-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|